The booster dose of Johnson & Johnson’s (JNJ) COVID-19 vaccine has been authorized for emergency use by the U.S. Food and Drug Administration (FDA) for people aged 18 and above. Notably, the dose should be administered minimum after two months following the primary vaccination with a single-shot Johnson & Johnson COVID-19 vaccine. Additionally, the booster dose has also been authorized for eligible individuals, who received a different authorized or approved COVID-19 vaccine. Markedly, the formulation and dosage of the booster shot are similar to the primary shot. The U.S. regulator’s decision followed a unanimous recommendation from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).
https://www.tipranks.com/news/johnson-johnsons-covid-19-vaccine-booster-dose-cleared-for-emergency-use-in-u-s?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Johnson and Johnson Charts.